[1]
|
Philips, C.A., Rajesh, S., Nair, D.C., et al. (2021) Hepatocellular Carcinoma in 2021: An Exhaustive Update. Cureus, 13, e19274. https://doi.org/10.7759/cureus.19274
|
[2]
|
Zhong, B.Y., Jiang, J.Q., Sun, J.H., et al. (2023) Prognostic Performance of the China Liver Cancer Staging System in Hepatocellular Carcinoma Following Transarterial Chemoem-bolization. Journal of Clinical and Translational Hepatology, 11, 1321-1328.
|
[3]
|
Adwan, H., Adwan, M. and Vogl, T.J. (2023) Combination Therapy of Bland Transarterial Embolization and Microwave Ablation for Hepatocellular Car-cinoma within the Milan Criteria Leads to Significantly Higher Overall Survival. Cancers, 15, Article 5076. https://doi.org/10.3390/cancers15205076
|
[4]
|
中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗指南(2022年版) [J]. 中华消化外科杂志, 2022, 21(2): 143-168.
|
[5]
|
Kudo, M. (2022) New Treatment Para-digm with Systemic Therapy in Intermediate-Stage Hepatocellular Carcinoma. International Journal of Clinical Oncology, 27, 1110-1119. https://doi.org/10.1007/s10147-022-02166-0
|
[6]
|
Korean Liver Cancer Association (KLCA) and National Cancer Center (NCC) Korea (2023) 2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepa-tocellular Carcinoma. Journal of Liver Cancer, 23, 1-120.
https://doi.org/10.17998/jlc.2022.11.07
|
[7]
|
Zhong, B.Y., Jin, Z.C., Chen, J.J., et al. (2023) Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma. Journal of Clinical and Translational Hepatology, 11, 480-489.
|
[8]
|
Zhang, S., Wang, W.S., Zhong, B.Y., et al. (2022) Subsequent Treatment after Transarterial Chemoem-bolization Failure/Refractoriness: A Review Based on Published Evidence. Journal of Clinical and Translational Hepa-tology, 10, 740-747. https://doi.org/10.14218/JCTH.2021.00336
|
[9]
|
Qiu, Z., Shen, L., Chen, S., et al. (2019) Ef-ficacy of Apatinib in Transcatheter Arterial Chemoembolization (TACE) Refractory Intermediate and Advanced-Stage Hepatocellular Carcinoma: A Propensity Score Matching Analysis. Cancer Management and Research, 11, 9321-9330. https://doi.org/10.2147/CMAR.S223271
|
[10]
|
Kaibori, M., Matsushima, H., Ishizaki, M., et al. (2021) The Impact of Sorafenib in Combination with Transarterial Chemoembolization on the Outcomes of Intermediate-Stage Hepatocellu-lar Carcinoma. Asian Pacific Journal of Cancer Prevention, 22, 1217-1224. https://doi.org/10.31557/APJCP.2021.22.4.1217
|
[11]
|
张申, 张磊, 仲斌演, 等. “TACE抵抗/失败”——需要全面认识[J]. 介入放射学杂志, 2020, 29(8): 743-747.
|
[12]
|
Lee, J.S., Kim, B.K., Kim, S.U., et al. (2020) A Survey on Transarterial Chemoembolization Refractoriness and a Real-World Treatment Pattern for Hepatocellular Carcinoma in Korea. Clinical and Molecular Hepatology, 26, 24-32.
https://doi.org/10.3350/cmh.2018.0065
|
[13]
|
Zhong, B.Y., Wang, W.S., Zhang, S., Zhu, H.D., et al. (2021) Re-Evaluating Transarterial Chemoembolization Failure/Refractoriness: A Survey by Chinese College of Interventional-ists. Journal of Clinical and Translational Hepatology, 9, 521-527.
|
[14]
|
中国医师协会介入医师分会临床诊疗指南专委会. 肝细胞癌经动脉化疗栓塞抵抗及后续治疗专家共识[J]. 中华内科杂志, 2022, 61(8): 860-866.
|
[15]
|
Kudo, M., Han, K.H., Ye, S.L., et al. (2020) A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Car-cinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements. Liver Cancer, 9, 245-260.
https://doi.org/10.1159/000507370
|
[16]
|
Liu, Y., Wang, J., Yang, R., et al. (2021) GP73-Mediated Secretion of AFP and GP73 Promotes Proliferation and Metastasis of Hepatocellular Carcinoma Cells. Oncogenesis, 10, Article No. 69.
https://doi.org/10.1038/s41389-021-00358-3
|
[17]
|
Liu, L., Huang, Y., Fu, Y., et al. (2022) Hepatitis B Virus Pro-motes Hepatocellular Carcinoma Development by Activating GP73 to Repress the Innate Immune Response. Infectious Agents and Cancer, 17, Article No. 52.
https://doi.org/10.1186/s13027-022-00462-y
|
[18]
|
Ali, O.M., El Amin, H.A., Sharkawy, Y.L., et al. (2020) Golgi Protein 73 versus α-Fetoprotein as a New Biomarker in Early Diagnosis of Hepatocellular Carcinoma. International Journal of General Medicine, 13, 193-200.
https://doi.org/10.2147/IJGM.S253622
|
[19]
|
李丹丹, 谭艳, 唐俊明, 等. 细胞上皮间充质转化转化态异质性及可塑性的最新研究进展[J]. 湖北医药学院学报, 2023, 42(2): 216-223.
|
[20]
|
Manfioletti, G. and Fedele, M. (2022) Epithelial-Mesenchymal Transition (EMT) 2021. International Journal of Molecular Sciences, 23, Article 5848. https://doi.org/10.3390/ijms23105848
|
[21]
|
马艳丽, 杨靖, 吕梦丽. KAI1, Snail, Slug, E-cadherin在鼻咽癌组织中的表达及其与患者预后的关系[J]. 实用癌症杂志, 2023, 38(4): 562-564, 568.
|
[22]
|
黄兴武, 罗锋, 阳国彬. miR-142-5p通过靶向作用WWP1对前列腺癌细胞PC-3生物学行为的影响[J]. 实用癌症杂志, 2022, 37(7): 1060-1067.
|
[23]
|
Orrapin, S., Udomruk, S., Lapisatepun, W., et al. (2022) Clinical Implication of Circulating Tumor Cells Expressing Epithelial Mesenchymal Transition (EMT) and Cancer Stem Cell (CSC) Markers and Their Perspective in HCC: A Systematic Review. Cancers, 14, Article 3373. https://doi.org/10.3390/cancers14143373
|
[24]
|
覃熙媛, 朱莹, 李伟滔, 等. 上皮性卵巢癌组织中FoxM1的表达及其临床意义[J]. 癌变∙畸变∙突变, 2023, 35(4): 273-278.
|
[25]
|
Bao, Y.X., Cao, Q., Yang, Y., et al. (2013) Expression and Prognostic Significance of Golgiglycopro-tein73 (GP73) with Epithelial-Mesenchymal Transition (EMT) Related Molecules in Hepatocellular Carcinoma (HCC). Diagnostic Pathology, 8, Article No. 197. https://doi.org/10.1186/1746-1596-8-197
|
[26]
|
Sun, Y., Yang, H., Mao, Y., et al. (2011) Increased Golgi Protein 73 Expression in Hepatocellular Carcinoma Tissue Correlates with Tumor Ag-gression But Not Survival. Journal of Gastroenterology and Hepatology, 26, 1207-1212.
https://doi.org/10.1111/j.1440-1746.2011.06733.x
|
[27]
|
Yang, Y., Liu, Q., Zhang, H., et al. (2017) Silencing of GP73 Inhibits Invasion and Metastasis via Suppression of Epithelial-Mesenchymal Transition in Hepatocellular Carci-noma. Oncology Reports, 37, 1182-1188.
https://doi.org/10.3892/or.2017.5351
|
[28]
|
Chen, J., Ding, Z.Y., Li, S., et al. (2021) Targeting Transforming Growth Factor-β Signaling for Enhanced Cancer Chemotherapy. Theranostics, 11, 1345-1363. https://doi.org/10.7150/thno.51383
|
[29]
|
Yang, Y., Liu, Q., Li, Z., et al. (2018) GP73 Promotes Epitheli-al-Mesenchymal Transition and Invasion Partly by Activating TGF-β1/Smad2 Signaling in Hepatocellular Carcinoma. Carcinogenesis, 39, 900-910.
https://doi.org/10.1093/carcin/bgy010
|
[30]
|
Pan, J., Zhang, Y.F., Yang, H.Y., et al. (2015) The Response of Golgi Protein 73 to Transcatheter Arterial Chemoembolization in Patients with Hepatocellular Carcinoma May Relate to the In-fluence of Certain Chemotherapeutics. Hepatobiliary & Pancreatic Diseases International, 14, 406-412. https://doi.org/10.1016/S1499-3872(15)60403-9
|
[31]
|
Ai, N., Liu, W., Li, Z.G., et al. (2017) High Expression of GP73 in Primary Hepatocellular Carcinoma and Its Function in the Assessment of Transcatheter Arterial Chemoemboli-zation. Oncology Letters, 14, 3953-3958.
https://doi.org/10.3892/ol.2017.6697
|
[32]
|
Khare, S., Khare, T., Ramanathan, R. and Ibdah, J.A. (2022) Hepatocel-lular Carcinoma: The Role of MicroRNAs. Biomolecules, 12, Article 645. https://doi.org/10.3390/biom12050645
|
[33]
|
Menon, A., Abd-Aziz, N., Khalid, K., et al. (2022) miRNA: A Prom-ising Therapeutic Target in Cancer. International Journal of Molecular Sciences, 23, Article 11502. https://doi.org/10.3390/ijms231911502
|
[34]
|
Rzeszutek, I. and Singh, A. (2020) Small RNAs, Big Diseases. Inter-national Journal of Molecular Sciences, 21, Article 5699. https://doi.org/10.3390/ijms21165699
|
[35]
|
Xu, X., Tao, Y., Shan, L., et al. (2018) The Role of MicroRNAs in Hepatocellular Carcinoma. Journal of Cancer, 9, 3557-3569. https://doi.org/10.7150/jca.26350
|
[36]
|
Hou, X., Yang, L., Jiang, X., et al. (2019) Role of microRNA-141-3p in the Progression and Metastasis of Hepatocellular Carcinoma Cell. International Journal of Biological Macromolecules, 128, 331-339.
https://doi.org/10.1016/j.ijbiomac.2019.01.144
|
[37]
|
Liu, Y., Ding, Y., Huang, J., et al. (2014) MiR-141 Suppress-es the Migration and Invasion of HCC Cells by Targeting Tiam1. PLOS ONE, 9, e88393. https://doi.org/10.1371/journal.pone.0088393
|
[38]
|
Ma, L., Shao, H., Chen, H., et al. (2021) The Mechanism of miR-141 Regulating the Proliferation and Metastasis of Liver Cancer Cells by Targeting STAT4. Journal of Oncology, 2021, Article ID: 5425491.
https://doi.org/10.1155/2021/5425491
|
[39]
|
Tao, S., Hou, Y., Diao, L., et al. (2022) Long Noncoding RNA Study: Genome-Wide Approaches. Genes & Diseases, 10, 2491-2510. https://doi.org/10.1016/j.gendis.2022.10.024
|
[40]
|
Yuan, J.H., Yang, F., Wang, F., Ma, J.Z., et al. (2014) A Long Noncoding RNA Activated by TGF-β Promotes the Invasion-Metastasis Cascade in Hepatocellular Carcinoma. Cancer Cell, 25, 666-681.
https://doi.org/10.1016/j.ccr.2014.03.010
|
[41]
|
Sun, T. and Wong, N. (2015) Transforming Growth Fac-tor-β-Induced Long Noncoding RNA Promotes Liver Cancer Metastasis via RNA-RNA Crosstalk. Hepatology, 61, 722-724. https://doi.org/10.1002/hep.27599
|